Halaven (eribulin mesylate) NDC 43624-002

NDC codes

FDA NDC Directory

Product NDC (as listed)43624-002Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43624-0002Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43624-002-01	43624000201	100 VIAL in 1 TRAY (43624-002-01) / 2 mL in 1 VIALMarketed from Apr 21, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Halaven
Generic name (nonproprietary): eribulin mesylate
Active ingredients: Eribulin mesylate — 1 mg/2mL
Dosage form: Injection
Route: Intravenous
Labeler: BSP Pharmaceuticals SpA
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 201532
Marketing start: Apr 21, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Microtubule Inhibition (Physiologic effect)
Identifiers: Product ID 43624-002_494dbaab-6ded-549d-e063-6394a90a4022SPL ID 494dbaab-6ded-549d-e063-6394a90a4022SPL set ID 8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6RxCUI 1045456, 1045460UNII AV9U0660CW
Pharmacologic class: Microtubule Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N443624000201 followed by a unit qualifier and the quantity

Package 43624-0002-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 26, 2026.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 201532

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 201532
Product	Strength	Form · route	Labeler	Product NDC
Halaveneribulin mesylate	Eribulin mesylate .5 mg/mL	InjectionIntravenous	Eisai Inc.	62856-389